Varda Space Industries raises $251.0M Series D (United States, Oct 2026)
Reach the investors backing rounds like this
Backed by Lux Capital, Natural Capital · verified emails and LinkedIn on Datapile
Varda raises $251M to leverage gravity in space for drug production - BioSpace
Varda Space Industries is a startup aiming to manufacture medicines in space, leveraging microgravity to create drugs with better bioavailability and stability than Earth-produced molecules. The company has raised $251 million in a Series D round led by Lux Capital and Natural Capital, valuing the company at $1.6 billion. This funding will support their mission to capitalize on falling space launch costs for pharmaceutical production.
Varda raises $251M to leverage gravity in space for drug production BioSpace
| Oct 08, 2026 | Natron Energy | $10.2M | — | United States |
| Oct 08, 2026 | Hone | $60.0M | Seed | United States |
| Oct 08, 2026 | Arena | $200.0M | Series B | United States |
| Oct 08, 2026 | Quaise Energy | $25.0M | Grant | United States |
21,942 investors back startups in United States
You just read who funded Varda Space Industries. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.